Leap Therapeutics Inc (NASDAQ: LPTX) on Friday, soared 9.36% from the previous trading day, before settling in for the closing price of $2.99. Within the past 52 weeks, LPTX’s price has moved between $1.68 and $5.00.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has dropped its sales by -20.00% annually for the last half of the decade. The company achieved an average annual earnings per share of 53.42%. With a float of $28.55 million, this company’s outstanding shares have now reached $38.26 million.
In an organization with 54 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 81.86%, operating margin of -10844.16%, and the pretax margin is -10075.87%.
Leap Therapeutics Inc (LPTX) Insider Updates
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Leap Therapeutics Inc is 25.48%, while institutional ownership is 31.82%.
Leap Therapeutics Inc (LPTX) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.38 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 53.42% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -2.49% during the next five years compared to 28.36% growth over the previous five years of trading.
Leap Therapeutics Inc (NASDAQ: LPTX) Trading Performance Indicators
Leap Therapeutics Inc (LPTX) is currently performing well based on its current performance indicators. A quick ratio of 3.97 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.93, a number that is poised to hit -0.40 in the next quarter and is forecasted to reach -1.28 in one year’s time.
Technical Analysis of Leap Therapeutics Inc (LPTX)
Let’s dig in a bit further. During the last 5-days, its volume was 0.67 million. That was better than the volume of 0.25 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 68.06%. Additionally, its Average True Range was 0.32.
During the past 100 days, Leap Therapeutics Inc’s (LPTX) raw stochastic average was set at 47.40%, which indicates a significant decrease from 83.34% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 77.01% in the past 14 days, which was lower than the 82.87% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.95, while its 200-day Moving Average is $2.64. However, in the short run, Leap Therapeutics Inc’s stock first resistance to watch stands at $3.42. Second resistance stands at $3.57. The third major resistance level sits at $3.80. If the price goes on to break the first support level at $3.04, it is likely to go to the next support level at $2.80. Assuming the price breaks the second support level, the third support level stands at $2.65.
Leap Therapeutics Inc (NASDAQ: LPTX) Key Stats
Market capitalization of the company is 137.03 million based on 38,318K outstanding shares. Right now, sales total 0 K and income totals -81,410 K. The company made 0 K in profit during its latest quarter, and -18,180 K in sales during its previous quarter.
